NHN Investment

Total investments

33

Average round size

9M

Portfolio companies

27

Rounds per year

2.36

Lead investments

2

Follow on index

0.18

Exits

3

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyE-CommerceInternetSoftwareArtificial IntelligenceHealth CareMessagingMarketingConsumer ElectronicsDeveloper APIs

Investments analytics

Analytics

Total investments
33
Lead investments
2
Exits
3
Rounds per year
2.36
Follow on index
0.18
Investments by industry
  • Software (9)
  • Health Care (7)
  • Biotechnology (5)
  • Artificial Intelligence (4)
  • Messaging (4)
  • Show 72 more
Investments by region
  • United States (16)
  • South Korea (11)
  • Israel (2)
  • United Kingdom (3)
  • Egypt (1)
Peak activity year
2019

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Avg. valuation at time of investment
13M
Group Appearance index
0.91
Avg. company exit year
5
Avg. multiplicator
4.24

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
Avegant04 Nov 2014Electronics (B2C), Augmented Reality, Virtual Reality, Consumer ElectronicsEarly Stage Venture9MUnited States, California
ImmunoMet Therapeutics08 Feb 2021Biotechnology, Health Care, Pharmaceutical, Therapeutics, BiopharmaEarly Stage Venture7MUnited States, Texas, Houston
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.